openPR Logo
Press release

Global T-Cell Immunotherapy Market Insights, Forecast

04-18-2019 02:19 PM CET | Health & Medicine

Press release from: Market Density

The global T-Cell Immunotherapy market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the T-Cell Immunotherapy market based on company, product type, end user and key regions. This report studies the global market size of T-Cell Immunotherapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of T-Cell Immunotherapy in these regions. This research report categorizes the global T-Cell Immunotherapy market by top players/brands, region, type and end user. This report also studies the global T-Cell Immunotherapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Adaptimmune Altor Bioscience Corporation Cellectis Juno Therapeutics Kite Pharma Novartis Takara Bio Unum Therapeutics Market size by Product CAR-T TCR TIL Therapies Market size by End User Stomach Cancer Lung Cancer Colorectal Cancer Esophagus Cancer Pancreatic Cancer Others Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global T-Cell Immunotherapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of T-Cell Immunotherapy market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global T-Cell Immunotherapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of T-Cell Immunotherapy submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of T-Cell Immunotherapy are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of T-Cell Immunotherapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=118316

Table of Contents:

Table of Contents

1 Study Coverage
1.1 T-Cell Immunotherapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global T-Cell Immunotherapy Market Size Growth Rate by Product
1.4.2 CAR-T
1.4.3 TCR
1.4.4 TIL Therapies
1.5 Market by End User
1.5.1 Global T-Cell Immunotherapy Market Size Growth Rate by End User
1.5.2 Stomach Cancer
1.5.3 Lung Cancer
1.5.4 Colorectal Cancer
1.5.5 Esophagus Cancer
1.5.6 Pancreatic Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global T-Cell Immunotherapy Market Size
2.1.1 Global T-Cell Immunotherapy Revenue 2014-2025
2.1.2 Global T-Cell Immunotherapy Sales 2014-2025
2.2 T-Cell Immunotherapy Growth Rate by Regions
2.2.1 Global T-Cell Immunotherapy Sales by Regions
2.2.2 Global T-Cell Immunotherapy Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 T-Cell Immunotherapy Sales by Manufacturers
3.1.1 T-Cell Immunotherapy Sales by Manufacturers
3.1.2 T-Cell Immunotherapy Sales Market Share by Manufacturers
3.1.3 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 T-Cell Immunotherapy Revenue by Manufacturers
3.2.1 T-Cell Immunotherapy Revenue by Manufacturers (2014-2019)
3.2.2 T-Cell Immunotherapy Revenue Share by Manufacturers (2014-2019)
3.3 T-Cell Immunotherapy Price by Manufacturers
3.4 T-Cell Immunotherapy Manufacturing Base Distribution, Product Types
3.4.1 T-Cell Immunotherapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T-Cell Immunotherapy Product Type
3.4.3 Date of International Manufacturers Enter into T-Cell Immunotherapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global T-Cell Immunotherapy Sales by Product
4.2 Global T-Cell Immunotherapy Revenue by Product
4.3 T-Cell Immunotherapy Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global T-Cell Immunotherapy Breakdown Data by End User

6 North America
6.1 North America T-Cell Immunotherapy by Countries
6.1.1 North America T-Cell Immunotherapy Sales by Countries
6.1.2 North America T-Cell Immunotherapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America T-Cell Immunotherapy by Product
6.3 North America T-Cell Immunotherapy by End User

7 Europe
7.1 Europe T-Cell Immunotherapy by Countries
7.1.1 Europe T-Cell Immunotherapy Sales by Countries
7.1.2 Europe T-Cell Immunotherapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe T-Cell Immunotherapy by Product
7.3 Europe T-Cell Immunotherapy by End User

8 Asia Pacific
8.1 Asia Pacific T-Cell Immunotherapy by Countries
8.1.1 Asia Pacific T-Cell Immunotherapy Sales by Countries
8.1.2 Asia Pacific T-Cell Immunotherapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific T-Cell Immunotherapy by Product
8.3 Asia Pacific T-Cell Immunotherapy by End User

9 Central & South America
9.1 Central & South America T-Cell Immunotherapy by Countries
9.1.1 Central & South America T-Cell Immunotherapy Sales by Countries
9.1.2 Central & South America T-Cell Immunotherapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America T-Cell Immunotherapy by Product
9.3 Central & South America T-Cell Immunotherapy by End User

10 Middle East and Africa
10.1 Middle East and Africa T-Cell Immunotherapy by Countries
10.1.1 Middle East and Africa T-Cell Immunotherapy Sales by Countries
10.1.2 Middle East and Africa T-Cell Immunotherapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa T-Cell Immunotherapy by Product
10.3 Middle East and Africa T-Cell Immunotherapy by End User

11 Company Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Company Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Adaptimmune T-Cell Immunotherapy Products Offered
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Products Offered
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Company Business Overview
11.3.Cellectis T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cellectis T-Cell Immunotherapy Products Offered
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Company Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Juno Therapeutics T-Cell Immunotherapy Products Offered
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Kite Pharma T-Cell Immunotherapy Products Offered
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis T-Cell Immunotherapy Products Offered
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Company Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Takara Bio T-Cell Immunotherapy Products Offered
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Company Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Unum Therapeutics T-Cell Immunotherapy Products Offered
11.8.5 Unum Therapeutics Recent Development

12 Future Forecast
12.1 T-Cell Immunotherapy Market Forecast by Regions
12.1.1 Global T-Cell Immunotherapy Sales Forecast by Regions 2019-2025
12.1.2 Global T-Cell Immunotherapy Revenue Forecast by Regions 2019-2025
12.2 T-Cell Immunotherapy Market Forecast by Product
12.2.1 Global T-Cell Immunotherapy Sales Forecast by Product 2019-2025
12.2.2 Global T-Cell Immunotherapy Revenue Forecast by Product 2019-2025
12.3 T-Cell Immunotherapy Market Forecast by End User
12.4 North America T-Cell Immunotherapy Forecast
12.5 Europe T-Cell Immunotherapy Forecast
12.6 Asia Pacific T-Cell Immunotherapy Forecast
12.7 Central & South America T-Cell Immunotherapy Forecast
12.8 Middle East and Africa T-Cell Immunotherapy Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T-Cell Immunotherapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-t-cell-immunotherapy-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,, Suite # 172,, San Jose, CA 95129

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global T-Cell Immunotherapy Market Insights, Forecast here

News-ID: 1709430 • Views: 151

More Releases from Market Density

Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and

All 5 Releases


More Releases for Immunotherapy

Immunotherapy Drugs Market Manoeuvre opportunities 2025
Global Immunotherapy Drugs Market: Snapshot Cancer immunotherapy requires the use of a body’s immune system to fight off cancer. The three types of immunotherapies available are passive, active, and hybrid. The core functionality of immunotherapy revolves around the presence of tissue-associated antigens, or TAA’s, which are molecules present on the surface of cancer cells. These are more commonly found as macromolecules such as carbohydrates, or proteins. In the case of active
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Allergy Treatment Market by Type & Immunotherapy
The global allergy treatment market is characterized by the dominance of a handful companies, namely ALK-Abelló A/S, Sallergenes Greer, and GlaxoSmithKline that hold leading revenue share, states Transparency Market Research (TMR) in a new report. The dominance of these companies is mainly because of their impressive product portfolio and extensive geographical outreach. Some other key names in the global allergy treatment market include Meda Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Allergan, Teva
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Immunotherapy: Mending Cancer Regimens 1.1 Preface to Cancer Immunotherapy 1.2 Evolution of Cancer Immunotherapy 2. Categorization of Cancer Immunotherapy 2.1 Specific Cancer Immunotherapy 2.1.1 Cancer Vaccines 2.1.2 Monoclonal Antibodies 2.2 Non-Specific Cancer Immunotherapy 2.2.1 Adoptive Cell Transfer Immunotherapy 2.2.2 Immune Checkpoint Inhibitors 3. Fundamentals
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics. Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being